Clarivate (NYSE:CLVT) Stock Price Down 5.2% – Time to Sell?

Clarivate PLC (NYSE:CLVT) shares were down 5.2% during mid-day trading on Monday . The company traded as low as $2.31 and last traded at $2.4560. 1,353,782 shares were traded during mid-day trading, a decline of 80% from the average daily volume of 6,680,027 shares. The stock had previously closed at $2.59.

Analyst Upgrades and Downgrades

CLVT has been the topic of a number of analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Clarivate in a research report on Wednesday, June 24th. Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Five research analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Reduce” and an average price target of $3.22.

Clarivate Price Performance

The firm has a fifty day moving average of $2.41 and a two-hundred day moving average of $2.58. The stock has a market capitalization of $1.60 billion, a P/E ratio of -11.83 and a beta of 1.38. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.84 and a quick ratio of 0.84.

Clarivate (NYSE:CLVT) last issued its earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.04. The company had revenue of $585.50 million for the quarter, compared to analysts’ expectations of $569.50 million. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The firm’s quarterly revenue was down 1.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.14 EPS. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. On average, analysts predict that Clarivate PLC will post 0.65 EPS for the current year.

Hedge Funds Weigh In On Clarivate

A number of hedge funds and other institutional investors have recently modified their holdings of CLVT. FIL Ltd boosted its position in Clarivate by 2.3% during the fourth quarter. FIL Ltd now owns 25,266,152 shares of the company’s stock valued at $84,389,000 after purchasing an additional 567,170 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Clarivate by 3.3% in the 3rd quarter. Dimensional Fund Advisors LP now owns 21,768,783 shares of the company’s stock worth $83,373,000 after buying an additional 696,903 shares during the last quarter. Atairos Partners GP Inc. raised its stake in shares of Clarivate by 195.3% during the 4th quarter. Atairos Partners GP Inc. now owns 10,232,667 shares of the company’s stock worth $34,177,000 after acquiring an additional 6,767,667 shares in the last quarter. Invenomic Capital Management LP raised its stake in shares of Clarivate by 3.8% during the 4th quarter. Invenomic Capital Management LP now owns 9,029,414 shares of the company’s stock worth $30,158,000 after acquiring an additional 326,369 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in Clarivate by 9.3% during the third quarter. Vanguard Group Inc. now owns 8,922,585 shares of the company’s stock valued at $34,173,000 after acquiring an additional 756,722 shares during the last quarter. 85.72% of the stock is currently owned by institutional investors.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.